Safety and Efficacy of Single Agent Adjuvant Trastuzumab (Herceptin) in Older Women With Early-Stage and Locally Advanced Breast Cancer: A Phase II Trial

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 07 May 2024

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

16 Jul 2020 Status changed from active, no longer recruiting to completed.
31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology
08 Jan 2019 Planned End Date changed from 1 Nov 2015 to 12 Jan 2020.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com